Kesar Pharma is a finished-dose manufacturer based in India. It appears in 79 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), FDA (GH) and DIGEMAPS (DO). Its GMP standing is certified by CDSCO (India) and NAFDAC (NG). Customs aggregates show $137K of exports covering 5 molecules to 3 destinations in 2025.
| Site | FDA FEI |
|---|---|
| l kalolbileshwarpur a 382 729gandhinagar, India | Not on file |
| GANDHINAGAR, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 50 | 1 |
| FDA (GH) | 19 | None |
| DIGEMAPS (DO) | 6 | None |
| UZPHARM (UZ) | 3 | None |
| ARCSA (EC) | 1 | None |
| CDSCO (India) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $137K | 3 |
| 2024 | Not reported | $395K | 4 |
| 2023 | Not reported | $1.0M | 3 |
| 2022 | Not reported | $2.2M | 6 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Kesar Pharma comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.